RecruitingPHASE1, PHASE2NCT03919240

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The First Affiliated Hospital of Soochow University
Principal Investigator
Depei Wu, M.D., Ph.D.
The First Affiliated Hospital of Soochow University
Intervention
CAR T-cell therapy(biological)
Enrollment
196 enrolled
Eligibility
All sexes
Timeline
20152025

Study locations (1)

Collaborators

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · The Second People's Hospital of Huai'an · Third Military Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03919240 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials